Jadon Scarlett
Story Poster
14:58
Defensive lineman Rodas Johnson says it's 'now or never' for the Ags
1 mo ago by Ali Russell
Senior Rodas Johnson got some much-needed rest during the bye week, even going on a hunting trip with his fellow defensive linemen. "Big Ro" sat down for an exclusive interview as the Fightin' Texas Aggies gear up to face New Mexico State on Saturday night.
Story Poster
29:04
Lunch with Liucci: Billy Liucci joins TexAgs Radio (Monday, August 7)
1 yr ago by Billy Liucci
TexAgs co-owner and executive editor Billy Liucci joined TexAgs Radio Monday morning to share his thoughts now that Texas A&M's fall camp is underway. Liucci also discussed Texas A&M's open practice on Sunday afternoon, standouts from camp and much more.
Story Poster
Three Things: Jadon Scarlett's arrival, 2024 quarterback options & more
1 yr ago by Jason Howell
As he does every Friday morning, TexAgs' senior recruiting analyst Jason Howell offered up another round of his weekly recruiting thoughts. In this edition of his three things, Howell discusses DL Jadon Scarlett, things that catch his eye and much more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
16:00
Recruiting Country: The latest recruiting news surrounding the Maroon & White
1 yr ago by Ryan Brauninger
TexAgs' recruiting analyst Ryan Brauninger joined TexAgs Radio on Wednesday morning for another edition of Recruiting Country, highlighting the latest news and notes from the recruiting trail now that the 2022 college football season is officially over.
Story Poster
Spring Ball Report: An in-depth look at the defensive side of the ball
2 yr ago by Billy Liucci
With the final week of spring practice nearing a close for Jimbo Fisher & Co., Billy Liucci goes in-depth on the position battles, performances to note and much more from the defensive side of the ball ahead of Saturday's Maroon & White Game at Kyle Field.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.